Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 9.09% is 59% below its 5-year average of 21.91%, near the low end of its 5-year range (6.57%–60.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.54% below its 12-month average of 12.05%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.09%.
DEBT TO ASSETS RATIO
9.09%
DEBT TO ASSETS RATIO AVG TTM
12.05%
DEBT TO ASSETS RATIO AVG 3Y
15.90%
DEBT TO ASSETS RATIO AVG 5Y
21.91%
DEBT TO ASSETS RATIO AVG 10Y
30.46%
DEBT TO ASSETS RATIO AVG 15Y
24.84%
DEBT TO ASSETS RATIO AVG 20Y
72.46%
CURRENT VS TTM AVG
-24.54%
CURRENT VS 3Y AVG
-42.83%
CURRENT VS 5Y AVG
-58.50%
CURRENT VS 10Y AVG
-70.15%
CURRENT VS 15Y AVG
-63.41%
CURRENT VS 20Y AVG
-87.45%
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
+6892.57%
vs the sector median at left
ABVC BioPharma, Inc.
Market Cap
$25.48M
Debt to Assets Ratio
9.09%
TTM Avg
12.05%
3Y Avg
15.90%
5Y Avg
21.91%
Market Cap
$24.44M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.90M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.93M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.92M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.36M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $25.48M | 9.09% | 12.05% | 15.90% | 21.91% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | 0.16% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 0.17% | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 0.08% | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.01% | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 0.19% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 0.26% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | N/A | N/A | N/A |
Debt/Assets
9.1%
Debt/Equity
0.17
Current Ratio
0.07
Interest Coverage
-17.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 9.09% |
| 2026-03-31 | 13.84% |
| 2025-12-31 | 16.49% |
| 2025-09-30 | 6.57% |
| 2025-06-30 | 14.25% |
| 2025-03-31 | 20.10% |
| 2024-12-31 | 42.49% |
| 2024-09-30 | 18.98% |
| 2024-06-30 | 18.70% |
| 2024-03-31 | 18.48% |
| 2023-12-31 | 35.56% |
| 2023-09-30 | 22.51% |
| 2023-06-30 | 60.26% |
| 2023-03-31 | 55.01% |
| 2022-12-31 | 31.23% |
| 2022-09-30 | 31.66% |
| 2022-06-30 | 21.36% |
| 2022-03-31 | 24.39% |
| 2021-12-31 | 24.38% |
| 2021-09-30 | 24.22% |
| 2021-06-30 | 56.04% |
| 2021-03-31 | 48.91% |
| 2020-12-31 | 45.85% |
| 2020-09-30 | 74.77% |
| 2020-06-30 | 48.32% |
| 2020-03-31 | 77.47% |
| 2019-12-31 | 71.28% |
| 2019-09-30 | 55.87% |
| 2019-06-30 | 50.11% |
| 2019-03-31 | 50.48% |
| 2018-12-31 | 830.97% |
| 2018-09-30 | 21.20% |
| 2018-06-30 | 20.76% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 149.30% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 57.12% |
| 2016-03-31 | 1.14% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 10.26% |
| 2015-06-30 | 10.39% |
| 2015-03-31 | 10.84% |
| 2014-12-31 | 10.84% |
| 2014-09-30 | 10.84% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 490.80% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 452.97% |
| 2012-12-31 | 418.89% |
| 2012-09-30 | 369.06% |
| 2012-06-30 | 270.11% |
| 2012-03-31 | 295.45% |
| 2011-12-15 | 332.28% |
| 2011-08-03 | 311.41% |
| 2011-06-30 | 293.01% |
| 2011-03-31 | 371.76% |
| 2010-12-31 | 529.60% |
| 2010-09-30 | 479.91% |
| 2010-05-21 | 385.50% |
| 2010-02-08 | 307.69% |
| 2009-12-31 | 0.06% |
| 2009-09-30 | 162.15% |
| 2009-06-30 | 158.13% |
| 2009-03-31 | 164.84% |
| 2008-12-31 | 179.01% |
| 2008-09-30 | 75.74% |
| 2008-06-30 | 329.35% |
| 2008-03-31 | 148.83% |
| 2007-12-31 | 94.84% |
| 2007-09-30 | 34.17% |
| 2007-06-30 | 1809.19% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 9.09% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 75.00% |
